BioLife Solutions Inc (BLFS)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 412,714 | 450,229 | 554,286 | 234,829 | 92,816 |
| Total stockholders’ equity | US$ in thousands | 337,663 | 364,188 | 478,047 | 204,429 | 43,321 |
| Financial leverage ratio | 1.22 | 1.24 | 1.16 | 1.15 | 2.14 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $412,714K ÷ $337,663K
= 1.22
The financial leverage ratio of BioLife Solutions Inc has shown some fluctuations over the past five years. The ratio measures how much the company relies on debt to finance its operations.
In 2019, the financial leverage ratio was at a relatively high level of 2.14, indicating a significant reliance on debt to fund its activities. This may have raised concerns about the company's financial risk and ability to meet its debt obligations.
In the following years, the ratio decreased to 1.15 in 2020 and further to 1.16 in 2021, suggesting a reduction in the company's debt levels and a move towards a more conservative capital structure.
However, there was a slight increase in the financial leverage ratio to 1.24 in 2022 and then a decrease to 1.22 in 2023. These fluctuations may indicate some variability in the company's debt management and capital structure decisions.
Overall, while there have been some fluctuations in the financial leverage ratio of BioLife Solutions Inc, the company seems to have made efforts to moderate its reliance on debt over the observed period. It will be important to monitor this ratio in the future to ensure that the company maintains a healthy balance between debt and equity in its capital structure.
Peer comparison
Dec 31, 2023